ProPhase Labs, Inc. Cost of Revenue
ProPhase Labs, Inc. (PRPH) reported Cost of Revenue of $785.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-19
- ProPhase Labs, Inc. cost of goods and services sold for the quarter ending 2026-06-30 was $785.00K, a 53.02% increase year-over-year.
- ProPhase Labs, Inc. cost of goods and services sold for the quarter ending 2026-03-31 was $874.00K, a 3.43% decline year-over-year.
- ProPhase Labs, Inc. cost of goods and services sold for the quarter ending 2025-12-31 was $537.00K, a 67.34% decline year-over-year.
- ProPhase Labs, Inc. cost of goods and services sold for the quarter ending 2025-09-30 was $1.01M, a 16.24% decline year-over-year.
- ProPhase Labs, Inc. cost of goods and services sold for fiscal 2025 was $2.96M, a 57.21% decline from fiscal 2024.
- ProPhase Labs, Inc. cost of goods and services sold for fiscal 2024 was $6.92M, a 64.38% decline from fiscal 2023.
- ProPhase Labs, Inc. cost of goods and services sold for fiscal 2023 was $19.43M, a 62.63% decline from fiscal 2022.
- ProPhase Labs, Inc. cost of goods and services sold for fiscal 2022 was $51.99M, a 40.32% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 3 month as first filed | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 6 month as first filed | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 9 month as first filed | Cost of Goods and Services Sold 12 month | Cost of Goods and Services Sold 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $785.00K 10-Q · filed 2026-08-19 | $1.66M 10-Q · filed 2026-08-19 | $2.20M derived: sum of 3 quarters · filed 2026-08-19 | $3.20M derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2026-03-31 | $874.00K 10-Q/A · filed 2026-07-09 | $311.00K 10-Q · filed 2026-06-30 | $1.41M derived: sum of 2 quarters · filed 2026-07-09 | $2.42M derived: sum of 3 quarters · filed 2026-07-09 | $2.93M derived: sum of 4 quarters · filed 2026-08-19 | |||
| 2025-12-31 | $537.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-01 | $1.54M derived: sum of 2 quarters · filed 2026-06-01 | $2.06M derived: sum of 3 quarters · filed 2026-08-19 | $2.96M 10-K · filed 2026-06-01 | ||||
| 2025-09-30 | $1.01M 10-Q · filed 2025-11-19 | $1.52M derived: sum of 2 quarters · filed 2026-08-19 | $2.42M 10-Q · filed 2025-11-19 | $4.07M derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2025-06-30 | $513.00K 10-Q · filed 2026-08-19 | $1.42M 10-Q · filed 2026-08-19 | $3.06M derived: sum of 3 quarters · filed 2026-08-19 | $4.26M derived: sum of 4 quarters · filed 2026-08-19 | ||||
| 2025-03-31 | $905.00K 10-Q/A · filed 2026-07-09 | $2.55M derived: sum of 2 quarters · filed 2026-07-09 | $3.75M derived: sum of 3 quarters · filed 2026-07-09 | $5.41M derived: sum of 4 quarters · filed 2026-07-09 | ||||
| 2024-12-31 | $1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-01 | $2.85M derived: sum of 2 quarters · filed 2026-06-01 | $4.50M derived: sum of 3 quarters · filed 2026-06-01 | $6.92M 10-K · filed 2026-06-01 | ||||
| 2024-09-30 | $1.20M 10-Q · filed 2025-11-19 | $3.31M 10-Q · filed 2024-11-13 | $2.86M derived: sum of 2 quarters · filed 2025-11-19 | $5.28M 10-Q · filed 2025-11-19 | $10.33M 10-Q · filed 2024-11-13 | $3.11M derived: sum of 4 quarters · filed 2025-11-19 | ||
| 2024-06-30 | $1.66M 10-Q · filed 2025-08-13 | $2.95M 10-Q · filed 2024-08-14 | $4.08M 10-Q · filed 2025-08-13 | $7.02M 10-Q · filed 2024-08-14 | $1.91M derived: sum of 3 quarters · filed 2025-08-13 | $7.95M derived: sum of 4 quarters · filed 2025-08-13 | ||
| 2024-03-31 | $2.42M 10-Q · filed 2025-05-20 | $4.07M 10-Q · filed 2024-05-10 | $254.00K derived: sum of 2 quarters · filed 2025-05-20 | $6.29M derived: sum of 3 quarters · filed 2025-05-20 | $13.06M derived: sum of 4 quarters · filed 2025-05-20 | |||
| 2023-12-31 | -$2.16M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01 | $3.88M derived: sum of 2 quarters · filed 2025-04-01 | $10.64M derived: sum of 3 quarters · filed 2025-04-01 | $19.43M 10-K · filed 2025-04-01 | $28.14M 10-K · filed 2024-03-29 | |||
| 2023-09-30 | $6.04M 10-Q · filed 2024-11-13 | $12.81M derived: sum of 2 quarters · filed 2024-11-13 | $21.59M 10-Q · filed 2024-11-13 | $32.13M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $6.77M 10-Q · filed 2024-08-14 | $15.55M 10-Q · filed 2024-08-14 | $26.09M derived: sum of 3 quarters · filed 2024-08-14 | $38.32M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $8.78M 10-Q · filed 2024-05-10 | $19.32M derived: sum of 2 quarters · filed 2024-05-10 | $31.55M derived: sum of 3 quarters · filed 2024-05-10 | $41.92M derived: sum of 4 quarters · filed 2024-05-10 | ||||
| 2022-12-31 | $10.54M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $22.77M derived: sum of 2 quarters · filed 2024-03-29 | $33.14M derived: sum of 3 quarters · filed 2024-03-29 | $51.99M 10-K · filed 2024-03-29 | ||||
| 2022-09-30 | $12.23M 10-Q · filed 2023-11-13 | $22.60M derived: sum of 2 quarters · filed 2023-11-13 | $41.45M 10-Q · filed 2023-11-13 | $61.99M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $10.37M 10-Q · filed 2023-08-11 | $29.23M 10-Q · filed 2023-08-11 | $49.77M derived: sum of 3 quarters · filed 2023-08-11 | $55.26M derived: sum of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | $18.85M 10-Q · filed 2023-05-12 | $39.39M derived: sum of 2 quarters · filed 2023-05-12 | $44.89M derived: sum of 3 quarters · filed 2023-05-12 | $49.56M derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | $20.54M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $26.03M derived: sum of 2 quarters · filed 2023-03-29 | $30.71M derived: sum of 3 quarters · filed 2023-03-29 | $37.05M 10-K · filed 2023-03-29 | ||||
| 2021-09-30 | $5.50M 10-Q · filed 2022-11-10 | $10.17M derived: sum of 2 quarters · filed 2022-11-10 | $16.52M 10-Q · filed 2022-11-10 | $19.81M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $4.68M 10-Q · filed 2022-08-12 | $11.02M 10-Q · filed 2022-08-12 | $14.31M derived: sum of 3 quarters · filed 2022-08-12 | $17.11M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | $6.34M 10-Q · filed 2022-05-13 | $9.64M derived: sum of 2 quarters · filed 2022-05-13 | $12.44M derived: sum of 3 quarters · filed 2022-05-13 | $14.78M derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | $3.29M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $6.09M derived: sum of 2 quarters · filed 2022-03-31 | $8.44M derived: sum of 3 quarters · filed 2022-03-31 | $9.91M 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | $2.80M 10-Q · filed 2021-11-12 | $5.14M derived: sum of 2 quarters · filed 2021-11-12 | $6.62M 10-Q · filed 2021-11-12 | $8.76M derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | $2.34M 10-Q · filed 2021-08-13 | $3.82M 10-Q · filed 2021-08-13 | $5.96M derived: sum of 3 quarters · filed 2021-08-13 | $7.89M derived: sum of 4 quarters · filed 2021-08-13 | ||||
| 2020-03-31 | $1.47M 10-Q · filed 2021-05-14 | $3.61M derived: sum of 2 quarters · filed 2021-05-14 | $5.55M derived: sum of 3 quarters · filed 2021-05-14 | $6.94M derived: sum of 4 quarters · filed 2021-05-14 | ||||
| 2019-12-31 | $2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $4.07M derived: sum of 2 quarters · filed 2021-03-31 | $5.46M derived: sum of 3 quarters · filed 2021-03-31 | $7.26M 10-K · filed 2021-03-31 | ||||
| 2019-09-30 | $1.93M 10-Q · filed 2020-11-19 | $3.32M derived: sum of 2 quarters · filed 2020-11-19 | $5.12M 10-Q · filed 2020-11-19 | $7.87M derived: sum of 4 quarters · filed 2020-11-19 | ||||
| 2019-06-30 | $1.39M 10-Q · filed 2020-08-11 | $3.19M 10-Q · filed 2020-08-11 | $5.94M derived: sum of 3 quarters · filed 2020-08-11 | $7.62M derived: sum of 4 quarters · filed 2020-08-11 | ||||
| 2019-03-31 | $1.80M 10-Q · filed 2020-05-12 | $4.55M derived: sum of 2 quarters · filed 2020-05-12 | $6.23M derived: sum of 3 quarters · filed 2020-05-12 | $8.16M derived: sum of 4 quarters · filed 2020-05-12 | ||||
| 2018-12-31 | $2.75M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $4.43M derived: sum of 2 quarters · filed 2020-03-26 | $6.36M derived: sum of 3 quarters · filed 2020-03-26 | $8.35M 10-K · filed 2020-03-26 | ||||
| 2018-09-30 | $1.68M 10-Q · filed 2019-11-12 | $3.61M derived: sum of 2 quarters · filed 2019-11-12 | $5.59M 10-Q · filed 2019-11-12 | $8.45M derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2018-06-30 | $1.93M 10-Q · filed 2019-08-12 | $3.91M 10-Q · filed 2019-08-12 | $6.77M derived: sum of 3 quarters · filed 2019-08-12 | $9.38M derived: sum of 4 quarters · filed 2019-08-12 | ||||
| 2018-03-31 | $1.98M 10-Q · filed 2019-05-14 | $4.84M derived: sum of 2 quarters · filed 2019-05-14 | $7.45M derived: sum of 3 quarters · filed 2019-05-14 | $9.21M derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | $2.86M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $5.47M derived: sum of 2 quarters · filed 2019-03-26 | $7.23M derived: sum of 3 quarters · filed 2019-03-26 | $7.92M 10-K · filed 2019-03-26 | ||||
| 2017-09-30 | $2.61M 10-Q · filed 2018-11-14 | $4.37M derived: sum of 2 quarters · filed 2018-11-14 | $5.06M 10-Q · filed 2018-11-14 | $5.34M derived: sum of 4 quarters · filed 2018-11-14 | ||||
| 2017-06-30 | $1.76M 10-Q/A · filed 2018-08-20 | $2.45M 10-Q/A · filed 2018-08-20 | $2.73M derived: sum of 3 quarters · filed 2018-08-20 | $3.94M derived: sum of 4 quarters · filed 2018-08-20 | ||||
| 2017-03-31 | $686.00K 10-Q/A · filed 2018-08-20 | $966.00K derived: sum of 2 quarters · filed 2018-08-20 | $2.17M derived: sum of 3 quarters · filed 2018-08-20 | $3.16M derived: sum of 4 quarters · filed 2018-08-20 | ||||
| 2016-12-31 | $280.00K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2018-08-20 | $1.49M derived: sum of 2 quarters · filed 2018-08-20 | $2.48M derived: sum of 3 quarters · filed 2018-08-20 | $3.21M 10-K/A · filed 2018-08-20 | $10.95M 10-K · filed 2017-02-24 | |||
| 2016-09-30 | $1.21M 10-Q/A · filed 2018-08-20 | $3.03M 10-Q · filed 2016-11-14 | $2.20M derived: sum of 2 quarters · filed 2018-08-20 | $2.93M 10-Q/A · filed 2018-08-20 | $7.18M 10-Q · filed 2016-11-14 | -$437.00K derived: sum of 4 quarters · filed 2018-08-20 | ||
| 2016-06-30 | $993.00K 10-Q/A · filed 2018-08-20 | $1.72M 10-Q · filed 2016-08-11 | $1.72M 10-Q/A · filed 2018-08-20 | $4.15M 10-Q · filed 2016-08-11 | -$1.64M derived: sum of 3 quarters · filed 2018-08-20 | $29.00K derived: sum of 4 quarters · filed 2018-08-20 | ||
| 2016-03-31 | $731.00K 10-Q/A · filed 2018-08-20 | $2.43M 10-Q · filed 2016-05-13 | -$2.63M derived: sum of 2 quarters · filed 2018-08-20 | -$964.00K derived: sum of 3 quarters · filed 2018-08-20 | $220.00K derived: sum of 4 quarters · filed 2018-08-20 | |||
| 2015-12-31 | -$3.37M derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-08-20 | -$1.70M derived: sum of 2 quarters · filed 2018-08-20 | -$511.00K derived: sum of 3 quarters · filed 2018-08-20 | $1.69M 10-K/A · filed 2018-08-20 | $8.43M 10-K · filed 2016-03-29 | |||
| 2015-09-30 | $1.67M 10-Q · filed 2016-11-14 | $2.85M derived: sum of 2 quarters · filed 2016-11-14 | $5.05M 10-Q · filed 2016-11-14 | $8.13M derived: sum of 4 quarters · filed 2017-02-24 | ||||
| 2015-06-30 | $1.18M 10-Q · filed 2016-08-11 | $3.38M 10-Q · filed 2016-08-11 | $6.46M derived: sum of 3 quarters · filed 2017-02-24 | $8.08M derived: sum of 4 quarters · filed 2017-02-24 | ||||
| 2015-03-31 | $2.20M 10-Q · filed 2016-05-13 | $5.27M derived: sum of 2 quarters · filed 2017-02-24 | $6.89M derived: sum of 3 quarters · filed 2017-02-24 | $7.90M derived: sum of 4 quarters · filed 2017-02-24 | ||||
| 2014-12-31 | $3.08M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $4.70M derived: sum of 2 quarters · filed 2017-02-24 | $5.70M derived: sum of 3 quarters · filed 2017-02-24 | $7.89M 10-K · filed 2017-02-24 | ||||
| 2014-09-30 | $1.62M 10-Q · filed 2015-11-13 | $2.63M derived: sum of 2 quarters · filed 2015-11-13 | $4.82M 10-Q · filed 2015-11-13 | $7.83M derived: sum of 4 quarters · filed 2016-03-29 | ||||
| 2014-06-30 | $1.00M 10-Q · filed 2015-08-12 | $3.20M 10-Q · filed 2015-08-12 | $6.21M derived: sum of 3 quarters · filed 2016-03-29 | $8.34M derived: sum of 4 quarters · filed 2016-03-29 | ||||
| 2014-03-31 | $2.19M 10-Q · filed 2015-05-13 | $5.21M derived: sum of 2 quarters · filed 2016-03-29 | $7.34M derived: sum of 3 quarters · filed 2016-03-29 | $8.35M derived: sum of 4 quarters · filed 2016-03-29 | ||||
| 2013-12-31 | $3.02M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $5.15M derived: sum of 2 quarters · filed 2016-03-29 | $6.16M derived: sum of 3 quarters · filed 2016-03-29 | $8.36M 10-K · filed 2016-03-29 | ||||
| 2013-09-30 | $2.13M 10-Q · filed 2014-11-13 | $3.14M derived: sum of 2 quarters · filed 2014-11-13 | $5.35M 10-Q · filed 2014-11-13 | $8.74M derived: sum of 4 quarters · filed 2015-03-27 | ||||
| 2013-06-30 | $1.01M 10-Q · filed 2014-08-12 | $3.21M 10-Q · filed 2014-08-12 | $6.61M derived: sum of 3 quarters · filed 2015-03-27 | $8.62M derived: sum of 4 quarters · filed 2015-03-27 | ||||
| 2013-03-31 | $2.20M 10-Q · filed 2014-05-12 | $5.59M derived: sum of 2 quarters · filed 2015-03-27 | $7.61M derived: sum of 3 quarters · filed 2015-03-27 | $8.68M derived: sum of 4 quarters · filed 2015-03-27 | ||||
| 2012-12-31 | $3.39M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27 | $5.41M derived: sum of 2 quarters · filed 2015-03-27 | $6.48M derived: sum of 3 quarters · filed 2015-03-27 | $8.15M 10-K · filed 2015-03-27 | ||||
| 2012-09-30 | $2.02M 10-Q · filed 2013-11-13 | $3.08M derived: sum of 2 quarters · filed 2013-11-13 | $4.76M 10-Q · filed 2013-11-13 | $7.43M derived: sum of 4 quarters · filed 2014-03-27 | ||||
| 2012-06-30 | $1.07M 10-Q · filed 2013-08-13 | $2.75M 10-Q · filed 2013-08-13 | $5.41M derived: sum of 3 quarters · filed 2014-03-27 | $6.90M derived: sum of 4 quarters · filed 2014-03-27 | ||||
| 2012-03-31 | $1.68M 10-Q · filed 2013-05-10 | $4.34M derived: sum of 2 quarters · filed 2014-03-27 | $5.83M derived: sum of 3 quarters · filed 2014-03-27 | $6.68M derived: sum of 4 quarters · filed 2014-03-27 | ||||
| 2011-12-31 | $2.66M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $4.15M derived: sum of 2 quarters · filed 2014-03-27 | $5.00M derived: sum of 3 quarters · filed 2014-03-27 | $6.17M 10-K · filed 2014-03-27 | ||||
| 2011-09-30 | $1.49M 10-Q · filed 2012-11-14 | $2.33M derived: sum of 2 quarters · filed 2012-11-14 | $3.51M 10-Q · filed 2012-11-14 | $6.12M derived: sum of 4 quarters · filed 2013-03-28 | ||||
| 2011-06-30 | $848.00K 10-Q · filed 2012-08-13 | $2.02M 10-Q · filed 2012-08-13 | $4.63M derived: sum of 3 quarters · filed 2013-03-28 | $6.23M derived: sum of 4 quarters · filed 2013-03-28 | ||||
| 2011-03-31 | $1.17M 10-Q · filed 2012-05-11 | $3.79M derived: sum of 2 quarters · filed 2013-03-28 | $5.38M derived: sum of 3 quarters · filed 2013-03-28 | $6.04M derived: sum of 4 quarters · filed 2013-03-28 | ||||
| 2010-12-31 | $2.61M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $4.21M derived: sum of 2 quarters · filed 2013-03-28 | $4.87M derived: sum of 3 quarters · filed 2013-03-28 | $5.67M 10-K · filed 2013-03-28 | ||||
| 2010-09-30 | $1.59M 10-Q · filed 2011-11-14 | $2.25M derived: sum of 2 quarters · filed 2011-11-14 | $3.06M 10-Q · filed 2011-11-14 | |||||
| 2010-06-30 | $660.00K 10-Q · filed 2011-08-12 | $1.47M 10-Q · filed 2011-08-12 | ||||||
| 2009-12-31 | $8.25M 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |